N-Terminal Pro-B-Type Natriuretic Peptide and Echocardiographic Abnormalities in Severely Obese Patients: Correlation with Visceral Fat
Open Access
- 1 June 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 52 (6) , 1211-1213
Abstract
Many studies have confirmed NT-proBNP as a sensitive marker for left ventricular hypertrophy and/or asymptomatic left ventricular dysfunction (2)(3), and it is particularly reliable because of its high negative predictive value (4). To our knowledge, however, recent findings on the relationship between NT-proBNP and morphologic and dynamic cardiac abnormalities in obesity are still inconsistent and controversial. Rivera et al. (5) reported lower NT-proBNP concentrations in obese patients with heart failure compared with nonobese patients. Conversely, Hermann-Arnhof et al. (6) found that NT-proBNP concentrations were increased in obese individuals and were comparable to the values for New York Heart Association class I patients. Therefore, to gain further information on the utility of NT-proBNP as an indicator of possible preclinical cardiac disease in normotensive, severely obese individuals, we measured NT-proBNP concentrations in 27 severely obese women with no complications [mean (SD) body mass index, 43.5 (4.8) kg/m2 (median, 41.7 kg/m2); mean (SD) age, 33.3 (8.3) years (median, 31 years)] and 15 normal-weight patients. All participants were premenopausal, normotensive, normoglycemic, drug-free young women with normal renal function, who were not dyspneic; this excluded the possibility that high NT-proBNP concentrations might be associated with hypertension and diabetes (7)(8). All patients and controls underwent echocardiography (M-mode color Doppler; VSF Vingmed-System Five; General Electric). Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) areas in the obese group were assessed by computed tomography.Keywords
This publication has 18 references indexed in Scilit:
- Obese Subjects with Heart Failure Have Lower N-Terminal Pro-Brain Natriuretic Peptide Plasma Levels Irrespective of AetiologyEuropean Journal of Heart Failure, 2005
- Capability of B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP as Indicators of Cardiac Structural Disease in Asymptomatic Patients with Systemic Arterial HypertensionClinical Chemistry, 2005
- Increased Plasma Pro-B-Type Natriuretic Peptide in Infants of Women with Type 1 DiabetesClinical Chemistry, 2005
- N-Terminal Pro-B-Type Natriuretic Peptide as an Indicator of Possible Cardiovascular Disease in Severely Obese Individuals: Comparison with Patients in Different Stages of Heart FailureClinical Chemistry, 2005
- Brain and Other Natriuretic Peptides: Molecular AspectsEuropean Journal of Heart Failure, 2004
- Use of NT-proBNP in Routine Testing and Comparison to BNPEuropean Journal of Heart Failure, 2004
- B-type natriuretic peptide in cardiovascular diseaseThe Lancet, 2003
- Echocardiographic Abnormalities in Normotensive Obese Patients: Relationship with Visceral FatObesity Research, 2002
- Natriuretic peptides: a new lipolytic pathway in human adipocytesThe FASEB Journal, 2000
- Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular HypertrophyHypertension, 1996